Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1526-1532, April 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, P. M.
Right arrow Articles by Wells, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, P. M.
Right arrow Articles by Wells, P. G.

Genoprotection by UDP-Glucuronosyltransferases in Peroxidase-dependent, Reactive Oxygen Species-mediated Micronucleus Initiation by the Carcinogens 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Benzo[a]pyrene1

Perry M. Kim and Peter G. Wells2

Faculty of Pharmacy [P. M. K., P. G. W.] and Department of Pharmacology [P. G. W.], University of Toronto, Toronto, Ontario, Canada M5S 2S2

UDP-glucuronosyltransferases (UGTs) catalyze the glucuronidation and elimination of putative tobacco carcinogens such as benzo[a]pyrene (B[a]P) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which may reduce competing bioactivation and toxicity. B[a]P-initiated cytotoxicity and micronucleus formation, believed to reflect carcinogenic initiation, are enhanced in UGT-deficient rat fibroblasts, and UGTs may provide similar genoprotection against NNK. Using skin fibroblasts from wild-type UGT-normal (+/+) and congenic heterozygous (+/j) and homozygous (j/j) UGT-deficient rats, this study evaluated NNK in relation to B[a]P with respect to the mechanism of genotoxicity, evidenced by micro-nucleus formation, and genoprotection by UGTs. Molecular mechanisms were determined by changes in B[a]P- and NNK-initiated micronucleus formation when cells were incubated with the antioxidative enzyme superoxide dismutase (1680 IU/ml), inhibitors of cytochrome P450 (1 mM 1-aminobenzotriazole) and peroxidases (1-aminobenzotriazole; 40 µM eicosatetraynoic acid), and inducers of CYP1A1/2(10 mM 2,3,7,8-tetrachlorodibenzo-p-dioxin) and peroxidases [2,3,7,8-tetrachlorodibezo-p-dioxin; 0.625 ng/ml (0.0367 nM) interleukin 1{alpha}; 1 µM 12-O-tetradecanoylphorbol-13-acetate]. In +/+ fibroblasts, NNK and B[a]P initiated concentration-dependent, respective maximum 2.7-fold and 1.7-fold increases over DMSO controls in micronucleus formation (P < 0.05), with 10 µM NNK being 2.4-fold more genotoxic than B[a]P (P < 0.05). In both +/j and j/j UGT-deficient cells, micronuclei initiated by NNK and B[a]P each were over 2-fold higher than that in +/+ UGT normal cells (P < 0.05). Both NNK- and B[a]P-initiated micronuclei were decreased by superoxide dismutase and cytochrome P450/peroxidase inhibitors, while only that initiated by B[a]P was enhanced, up to 2.4-fold, by inducers, of which only interleukin 1a was effective in all UGT phenotypes (P < 0.05). These results provide the first evidence that: (a) UGTs may be genoprotective for NNK, with even heterozygous UGT deficiencies being toxicologically critical; and (b) peroxidase-catalyzed bioactivation, reactive oxygen species, and molecular target oxidation may contribute differentially to the genotoxicity of both NNK and B[a]P.

1 Supported by a grant from the Medical Research Council of Canada. Presented at the Annual Meeting of the Society of Toxicology, Anaheim, CA, March 1996 (Toxicologist, 16: 1188, 1996).

2 To whom requests for reprints should be addressed. Phone: (416) 978-3221; Fax: (416) 978-8511.

Received 10/ 9/95. Accepted 1/30/96.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
G. Chen, R. W. Dellinger, D. Sun, T. E. Spratt, and P. Lazarus
Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10
Drug Metab. Dispos., May 1, 2008; 36(5): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Miles, F. K. Kessler, L. J. Webb, P. C. Smith, and J. K. Ritter
Adenovirus-Mediated Gene Therapy to Restore Expression and Functionality of Multiple UDP-Glucuronosyltransferase 1A Enzymes in Gunn Rat Liver
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Butler, Y. Duguay, R. C. Millikan, R. Sinha, J.-F. Gagne, R. S. Sandler, and C. Guillemette
Joint Effects between UDP-Glucuronosyltransferase 1A7 Genotype and Dietary Carcinogen Exposure on Risk of Colon Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1626 - 1632.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, and C. H. Cho
The Modulating Role of Nuclear Factor-{kappa}B in the Action of {alpha}7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. W. Cheng, W. W. Lee, C. H. Li, C. C. Lee, and J. J. Kang
Genotoxicity of Motorcycle Exhaust Particles In Vivo and In Vitro
Toxicol. Sci., September 1, 2004; 81(1): 103 - 111.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. G. Wells, P. I. Mackenzie, J. Roy Chowdhury, C. Guillemette, P. A. Gregory, Y. Ishii, A. J. Hansen, F. K. Kessler, P. M. Kim, N. Roy Chowdhury, et al.
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
Drug Metab. Dispos., March 1, 2004; 32(3): 281 - 290.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Z. Hu and P. G. Wells
Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of In Vitro Benzo[a]pyrene Covalent Binding and Cytotoxicity
Toxicol. Sci., March 1, 2004; 78(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wiener, J.-L. Fang, N. Dossett, and P. Lazarus
Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes
Cancer Res., February 1, 2004; 64(3): 1190 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus
CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. PARMAN and P. G. WELLS
Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice
FASEB J, July 1, 2002; 16(9): 1001 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Luukkanen, J. Mikkola, T. Forsman, P. Taavitsainen, J. Taskinen, and E. Elovaara
Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
Drug Metab. Dispos., August 1, 2001; 29(8): 1096 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus
O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9
Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
N. Rioux and A. Castonguay
The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-{kappa}B
Carcinogenesis, September 1, 2000; 21(9): 1745 - 1751.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, A. J. Dannenberg, J. Y. Park, T. R. Tephly, and P. Lazarus
Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by Rat UDP-Glucuronosyltransferase 2B1
Drug Metab. Dispos., September 1, 1999; 27(9): 1010 - 1016.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
R. C.-T. Yu, T.-C. Lee, T.C. Wang, and J.-H. Li
Genetic toxicity of cocaine
Carcinogenesis, July 1, 1999; 20(7): 1193 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. M. Winn, P. M. Kim, and P. G. Wells
Investigation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone for In Vivo and In Vitro Murine Embryopathy and Embryonic ras Mutations
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1128 - 1135.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. M. Kim, L. M. Winn, T. Parman, and P. G. Wells
UDP-Glucuronosyltransferase-mediated Protection Against In Vitro DNA Oxidation and Micronucleus Formation Initiated by Phenytoin and Its Embryotoxic Metabolite 5-(p-Hydroxyphenyl)-5-phenylhydantoin
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 200 - 209.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.